A Deep Hydrophobic Binding Cavity is the Main Interaction for Different Y₂ R Antagonists

Area of Science:

• Pharmacology
• Neuroscience
• Structural Biology

Background:

• The neuropeptide Y2 receptor (Y2R) is implicated in epilepsy, mood disorders, angiogenesis, and tumor growth.
• Y2R is a significant target for therapeutic drug development.
• Understanding the Y2R binding pocket is key to designing selective antagonists for research.

Purpose of the Study:

• To investigate residues critical for Y2R antagonist binding using signal transduction assays.
• To model and analyze the binding site of Y2R antagonists BIIE0246 and SF-11 derivatives.
• To elucidate the structural basis for Y2R antagonism.

Main Methods:

• Signal transduction assays to identify crucial residues for antagonist interaction.
• Docking of antagonists into a comparative structural model of the Y2R.
• Analysis of antagonist binding site similarities and interactions.

Main Results:

• Several residues were identified as crucial for the interaction of BIIE0246 and SF-11 derivatives with Y2R.
• All investigated antagonists, despite structural differences, bind to a similar site.
• This binding site involves a deep hydrophobic cavity (TM4, 5, 6) and a hydrophobic patch (TM2, 7).
• Antagonists likely block Q3.32, a residue vital for Neuropeptide Y (NPY) binding and receptor activation.

Conclusions:

• Y2R antagonists share a conserved binding site, characterized by hydrophobic interactions.
• The findings provide structural insights into Y2R antagonism.
• This knowledge can guide the development of novel Y2R-targeting drugs.